NCT03129542View on ClinicalTrials.gov

Midodrine Hydrochloride in Early Sepsis

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

August 30, 2017

Primary Completion Date

April 28, 2020

Study Completion Date

May 15, 2020

Conditions
SepsisBlood Pressure
Interventions
DRUG

Midodrine Hydrochloride 10 milligrams

Three doses taken every 8 hours.

DRUG

Placebo capsule

Three doses taken every 8 hours.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Cleveland Clinic Abu Dhabi

OTHER

lead

Mayo Clinic

OTHER

NCT03129542 - Midodrine Hydrochloride in Early Sepsis | Biotech Hunter | Biotech Hunter